Unleashing the Power of Cellular Medicine
The Mygotic Process™ Is Transforming the Creation of Autologous Totipotent Cells from Somatic Cells While Erasing All Epigenetics Without Altering the DNA.
Current Stem cell therapies hold great promise to transform medical care but are confronting significant challenges to ensure their safe and effective use in the treatment of patients.
The Mygotic Process™ has Significant Advantages in Safety and Production Efficiency
The Transformational Mygotic Process™ is the Future for Creating Autologous Totipotent Cells from Somatic Cells
Somatic cells are reverted to the zygote phase and primed to become any cell type.
Zygotes have clear advantages due to their ability to differentiate into cells of all three germ layers.
Instantaneously yields a high percentage (40-70%) to Autologous Totipotent Clones.
Globally demethylated DNA is cleaned of all epigenetics.
The cells contain 2 pronuclei, laboratory produced zygotes – we call Mygotes™
Learn more at AmeboGenesis.com
Our website is coming soon.
To learn more: